Kevin Finney

Kevin Finney

Director/Miembro de la Junta en VAXART, INC. .

Fortuna: 110 979 $ al 30/06/2026

59 años
Health Technology
Consumer Services

Perfil

Kevin P.
Finney
was the founder of Zavante Therapeutics, Inc., founded in 2015, where the title held was Chief Operating Officer from 2015 to 2018.
Current jobs include Chairman, President & Chief Executive Officer at Autobahn Therapeutics, Inc. since 2019; Vice Chairman at Eirion Therapeutics, Inc. since 2016; and Independent Director at Vaxart, Inc. starting in 2025.
Former jobs include Chairman at Elsie Biotechnologies Inc. from 2021 to 2024; Director at Anterios, Inc. from 2015 to 2016; Director at TARIS BioMedical LLC from 2015 to 2019; President, Chief Operating Officer & Director at Abide Therapeutics, Inc. in 2019; and Head-World Wide Corporate Development at Allergan, Inc. from 2006 to 2015.
Education includes undergraduate studies at The California State University and an MBA from Pepperdine Graziadio Business School.

Participaciones conocidas en empresas públicas

EmpresaFechaNúmero de accionesValoraciónFecha de valoración
26/05/2026 183.437 ( 0,08 % ) 110 979 $ 30/06/2026

Cargos activos de Kevin Finney

EmpresasCargoInicio
VAXART, INC. Director/Miembro de la Junta 28/01/2025
Director/Miembro de la Junta 01/01/2016
Director Ejecutivo 01/11/2019

Antiguos cargos conocidos de Kevin Finney.

EmpresasCargoFin
Presidente 01/06/2024
Director/Miembro de la Junta 01/12/2019
Presidente 01/07/2019
Fundador 01/09/2018
Director/Miembro de la Junta 01/01/2016
Ver el detalle de la experiencia de Kevin Finney.

Formación de Kevin Finney.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

58

Relaciones de 1er grado

11

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas11

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology